Drugs that contain Cefiderocol Sulfate Tosylate

1. Drug name - FETROJA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9238657 SHIONOGI INC Cephalosporin having catechol group
Nov, 2031

(9 years from now)

US10004750 SHIONOGI INC Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof
Sep, 2035

(12 years from now)

CN102203100B SHIONOGI INC Cephalosporin Having A Catechol Group
Oct, 2029

(7 years from now)

CN102203100A SHIONOGI INC Cephalosporin Having Catechol Group
Oct, 2029

(7 years from now)

CN106795176A SHIONOGI INC Salt Of Cephalosporin Derivatives, Its Crystalline Solid And Its Manufacturing Method
Sep, 2035

(12 years from now)

CN106795176B SHIONOGI INC Salts Of Cephalosporin Derivatives, Crystalline Solid Thereof, And Process For Producing The Same
Sep, 2035

(12 years from now)

IN293935B SHIONOGI INC Cephalosporin Having Catechol Group
Oct, 2029

(7 years from now)

IN201101800P4 SHIONOGI INC Cephalosporin Having Catechol Group
Oct, 2029

(7 years from now)

EP2341053A1 SHIONOGI INC Cephalosporin Having Catechol Group
Oct, 2029

(7 years from now)

EP2341053B1 SHIONOGI INC Cephalosporin Having Catechol Group
Oct, 2029

(7 years from now)

EP2341053A4 SHIONOGI INC Cephalosporin Having Catechol Group
Oct, 2029

(7 years from now)

EP2960244B1 SHIONOGI INC Cephalosporin Having Catechol Group
Oct, 2029

(7 years from now)

EP2960244A1 SHIONOGI INC Cephalosporin Having Catechol Group
Oct, 2029

(7 years from now)

EP3190115A4 SHIONOGI INC Salt Of Cephalosporin Derivative, Crystalline Solid Form Of Same And Method For Producing Same
Sep, 2035

(12 years from now)

EP3190115A1 SHIONOGI INC Salt Of Cephalosporin Derivative, Crystalline Solid Form Of Same And Method For Producing Same
Sep, 2035

(12 years from now)

EP3190115B1 SHIONOGI INC Salt Of Cephalosporin Derivative, Crystalline Solid Form Of Same And Method For Producing Same
Sep, 2035

(12 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9949982 SHIONOGI INC Preparation containing cephalosporin having a catechol moiety Sep, 2035

(12 years from now)

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
EQ 1GM BASE/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.